Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

Clinical trial NCT07360132 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07360132
Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Non-small Cell Lung Cancer

Start date: 2026-01-15
Primary completion: 2028-04-10
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.